Modulation by retinoic acid of insulin-like growth factor (IGF) and IGF binding protein expression in human SK-N-SH neuroblastoma cells

European Journal of Endocrinology

Volumn 134, Issue 4, 1996, Pages 474-480

  Babajko, Sylvie ^a   Binoux, Michel ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL;

EID: 0030013794     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340474     Document Type: Article

References (42)

1. Suarez A, Hartmann O, Vassal G, Giron A, Habrand JL, Valteau D, et al. Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987. Med Pediatr Oncol 1991;19:473-7
2. Macaulay WM. Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-20
3. Melino G, Knight RA, Thiele CJ. New insight on the biology of neuroectodermal tumors. Cancer Res 1993;43:926-8
4. Christofori G, Naik P, Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 1994;369:414-7
5. Martin DM, Singleton JR, Meghani MA, Feldman EL. IGF receptor function and regulation in autocrine human neuroblastoma cell growth. Regul Peptides 1993;48:225-32
6. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechter MM, Israel MA. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest 1989;84:829-39
7. El-Badry OM, Helman LJ, Chatten J, Steinberg SM, Evans AE, Israel MA. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 1991;87:648-57
8. Martin DM, Feldman EL. Regulation of insulin-like growth factor-II expression and its role in autocrine growth of human neuroblastoma cells. J Cell Physiol 1993;155:290-300
9. Burke TW, Vuk-Pavlovic S. Insulin-like growth faclor-I is a serum component stimulating growth of human neuroblastoma. In Vitro Cell Dev Biol 1993;29A:391-4
10. Recio-Pinto E, Ishii DN. Insulin and insulin-like growth factor receptors regulating neurite formation in cultured human neuroblastoma cells. J Neurosci Res 1988;19:312-20
11. Shii DN, Wang C, Li Y. Second messengers mediating gene expression essential to neurite formation directed by insulin-like growth factors. In: Mohan K, LeRoith D, editors. Molecular biology and physiology of insulin-like growth factors. New York: Plenum Press, 1991:361-78
12. Lavenius E, Parrow V, Nanberg E, Pahlman S. Basic FGF and IGF-I promote differentiation of human SH-SY5Y neuroblastoma cells in culture. Growth Factors 1994;10:29-39
13. Bernardini S, Cianfarani S, Spagnoli A, Annicchiarico-Petruzzelli M, Melino G, Massoud R, et al. Expression and down-regulation by retinoic acid of IGF Binding protein-2 and -4 in medium from human neuroblastoma cells. J Neuroendocrinol 1994;6:409-13
14. McCusker RH, Clemmons DR. The insulin-like growth factor binding proteins: structure and biological functions. In: Schoffield PN, editor. Insulin-like growth factors. Structure and biological functions. Oxford: Oxford University Press, 1992:110-50
15. Thaller C, Eichele G. Identification and spatial distribution of retinoids in the developing chick limb. Nature 1987;302:150-3
16. Adamson PC. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer. Leukemia 1994;8: 1813-6
17. Matsumoto K, Gaetano C, Daughaday WH, Thiele CJ. Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line. Endocrinology 1992;130:3669-76
18. Melino G, Stephanou A, Annicchiarico-Petruzzelli M, Knight RA, Finazzi-Agro A, Lightman SL. Modulation of IGF-II expression during growth and differentiation of human neuroblastoma cells: retinoic acid may induce IGF-II. Neurosci Lett 1993;151:187-91
19. Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Instit 1983;4:741-7
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63
21. Binoux M, Seurin D, Lassarre C, Gourmelen M. Preferential measurement of insulin-like growth factor (IGF) I-regulated peptides in serum with the aid of IGF binding proteins (IGFBPs) produced by rat liver in culture. Estimation of serum IGFBP levels. J Clin Endocrinol Metab 1984;59:453-62
22. Binoux M, Lassarre C, Gourmelen M. Specific assay for insulin-like growth factor (IGF) II using the IGF binding proteins extracted from cerebrospinal fluid. J Clin Endocrinol Metab 1986;63: 1151-5
23. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 1986;154:138-43
24. Babajko S, Hardouin S, Segovia B, Groyer A, Binoux M. Expression of insulin-like growth factor binding protein-1 and -2 genes through the perinatal period in the rat. Endocrinology 1993;132:2586-92
25. Maniatis T, Fritsch EF, Sambrook J. Extraction, purification, and analysis of mRNA from eukaryotic cells. In: Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory, 1982:188-209
26. LeBouc Y, Noguiez P, Sondermeyer P, Dreyer D, Giard F, Binoux M. A new non-coding region for placental insulin-like growth factor II mRNA expression. FEBS Lett 1987;222:181-5
27. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong D. Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation. Mol Endocrinol 1990;4:1806-14
28. Mattson MEK, Engberg G, Ruusula A-I, Hall K, Pahlman S. Mitogenic response of human SH-SY5Y neuroblastoma cells to insulin-like growth factor I and II is dependent on the stage of differentiation. J Cell Biol 1986;102:1949-54
29. Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 1983;71:741-9
30. Kull FC, Jacobs S, Su YF, Svoboda ME, Van Wyk JJ, Cuatrecasas P. Monoclonal antibodies to receptor for insulin and somatomedin C. J Biol Chem 1983;258:6561-6
31. Gaetano C, Matsumoto K, Thiele CJ. Retinoic acid resistant neuroblastoma cells and the expression of insulin-like growth factor-II. Adv Neuroblastoma Res 1991;3:165-72
32. Binoux M, Lalou C, Lassarre C, Segovia B. Regulation of IGF bioavailability by IGFBP proteases. In: Baxter RC, Gluckman PD, Rosenfeld RG, editors. The insulin-like growth factors and their regulatory proteins. Proceedings of the Third International Symposium on IGFs. Amsterdam: Elsevier, 1994:217-26
33. Roghani M, Lassarre C, Zapf J, Povoa G, Binoux M. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. J Clin Endocrinol Metab 1991;73:658-66
34. Kiefer MC, Schmid C, Waldvogel M, Schläpfer I, Futo E, Masiarz FR, et al. Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization. Growth Regul 1993;3:56-9
35. Jones JI, Gockerman A, Busby WH, Wright G, Clemmons DR. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the a5β1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993;90:10553-7
36. Adamo ML, Shao Z-M, Lanau F, Chen JC, Clemmons DR, Roberts Jr CT, et al. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2. -3, and 4- gene expression and protein secretion in a breast cancer cell line. Endocrinology 1992;131:1858-66
37. Schmid C, Schläpfer I, Waldvogel M, Meier PJ, Schwander J, Böni-Schnetzler M, et al. Differential regulation of insulin-like growth factor binding protein (IGFBP)-2 mRNA in liver and bone cells by insulin and retinoic acid in vitro. FEBS Lett 1992;303:205-9
38. Martin JL, Coverley JA, Pattison ST, Baxter RC. Insulin-like growth factor binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology 1995;136:1219-26
39. Loret C, Leneuve P, Binoux M. IGF regulation of IGF binding protein synthesis in the human neuroblastoma cell line SH-SY5Y. 29th Annu Meet Eur Soc Paediatr Endocr [abstract]. 1990
40. Manni A, Badger B, Wei L, Zaenglein A, Grove R, Khin S, et al. Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Res 1994;54:2934-42
41. Kato M, Ishizaki A, Hellman U, Wernstedt C, Kyogoku M, Miyazono K, et al. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. J Biol Chem 1995;270:12373-9
42. Birnbaum RS, Wiren KM. Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts. Endocrinology 1994;135:223-30